Impact of t2r38 receptor polymorphisms on pseudomonas aeruginosa infection in cystic fibrosis

Andrew R. Turnbull, Ronan Murphy, Volker Behrends, Helena Lund-Palau, Ameze Simbo, Myril Mariveles, Eric W.F.W. Alton, Andrew Bush, Amelia Shoemark, Jane C. Davies

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1635-1638
Number of pages4
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume197
Issue number12
DOIs
Publication statusPublished - 15 Jun 2018
Externally publishedYes

Bibliographical note

Funding Information:
Supported by the National Institute for Health Research Respiratory Disease Biomedical Research Unit at the Royal Brompton & Harefield NHS Foundation Trust and Imperial College London. The Pseudomonas aeruginosa clinical isolate repository was established as part of the Strategic Research Centre for Pseudomonas Infection in Cystic Fibrosis, funded by the Cystic Fibrosis Trust (UK). The Facility for Imaging by Light Microscopy at Imperial College London is partially supported by funding from the Wellcome Trust (grant 104931/Z/14/Z) and the Biotechnology and Biological Sciences Research Council (grant BB/L015129/1).

Funding Information:
Supported by the NIH (1K08HL11207-01A1, KL2TR002317, R56HL131787, and 1R01HL139613-01), American Heart Association (AHA 15GRNT25080016 and AHA 17SDG33670199), Pulmonary Hypertension Association, Cardiovascular Medical Research and Education Fund, CHEST Foundation (Award in Pulmonary Arterial Hypertension), and Systemic Sclerosis Foundation.

Cite this